Back to results
US 2026/0263436 A1Published application
Capsid inhibitors for the treatment of hiv
AssigneeGilead Sciences, Inc.
InventorsLaura Elizabeth Bauer, Anna Chiu, Eric M. Gorman, Andrew Stephen Mulato, Martin Sunkwang Rhee, Charles William Rowe, Scott P. Sellers, Dimitrios Stefanidis, Winston C. Tse, Stephen R. Yant, Dana J. Levine
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to compounds of Formula (Ia) and (Ib): or a pharmaceutically acceptable salt thereof, which are useful in the treatment of an HIV infection in heavily treatment-experienced patients with multidrug resistant HIV infection.
Claims2
1-107. (canceled)
A pharmaceutical composition comprising a sodium salt of a compound of Formula (Ia):
- water, and PEG300, wherein the pharmaceutical composition is in the form of a solution comprising about 23.41 w/w % water, about 50.13 w/w % PEG 300, and about 26.46 w/w % of the sodium salt of the compound of Formula (Ia);
- and
- wherein the term “about” refers to ±5 w/w %.
Dependencies are inferred from the claim text.